PCHAlliance – a non-profit organisation which mobilises stakeholders to realise the full potential of personal connected health – presented Ipsos with the award at the Fall Member Summit yesterday, an event co-located with its 9th Annual Connected Health Conference in Boston, MA. The award was received by Ipsos Healthcare’s Head of Connected Health, Reena Sangar.
Commenting on its decision to recognise Ipsos, PCHAlliance said, “In its first year as a member of PCHAlliance, Ipsos Healthcare has contributed significantly to the Alliance’s efforts through its Global Connected Health Survey, Digital Doctor Survey, and new efforts related to Digital Therapeutics. Ipsos is also exploring cutting-edge approaches to studying behaviours related to personal connected health that can inform a push towards sustained use of technology.”
Michael Spedding, Global CEO of Ipsos Healthcare, added, “We are delighted to have been given this award and honoured to play a continuing role in furthering the PCHAlliance’s vital work. There is no question that Connected Health is a game-changer – and we believe that market research will be an essential component in understanding the current and future attitudes, behaviours, and unmet needs of all stakeholders involved.”
Ipsos Healthcare Launches Syndicated Pan-Cancer Testing Monitor in Australia
Ipsos Healthcare has announced the expansion of its syndicated Pan-Cancer Testing Monitor (PCTM) to the Australian market. The PCTM, which has been running in the US since 2016, measures and tracks the usage of pan-cancer tests, which are designed to test for a wide range of cancer types to help doctors make more informed treatment decisions.
Ipsos Healthcare Launches MS Patient Community Panel
Ipsos Healthcare, the global healthcare business of Ipsos, has announced the launch of its syndicated Multiple Sclerosis (MS) Patient Community Panel. This latest offer is part of the Ipsos Healthcare Global Patient Centre of Excellence, launched in 2018.